SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 28 filers reported holding SILENCE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $966,545 | +78.7% | 98,326 | 0.0% | 0.02% | +41.2% |
| Q2 2023 | $540,793 | -8.6% | 98,326 | +3.1% | 0.02% | -5.6% |
| Q1 2023 | $591,375 | -99.9% | 95,383 | +19.8% | 0.02% | +20.0% |
| Q3 2022 | $786,000,000 | +130.5% | 79,636 | +176.4% | 0.02% | +200.0% |
| Q2 2022 | $341,000,000 | – | 28,816 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,284,133 | $19,583,028 | 7.36% |
| TCG Crossover Management, LLC | 2,104,875 | $32,099,344 | 5.66% |
| M28 Capital Management LP | 145,900 | $2,224,975 | 2.12% |
| Lombard Odier Asset Management (Europe) Ltd | 3,218,200 | $49,077,550 | 1.99% |
| Lombard Odier Asset Management (USA) Corp | 3,875,734 | $50,594,057 | 1.29% |
| Deep Track Capital, LP | 1,951,580 | $29,761,595 | 1.25% |
| BVF INC/IL | 1,508,416 | $23,003,344 | 0.97% |
| Frazier Life Sciences Management, L.P. | 881,173 | $13,437,888 | 0.84% |
| Parkman Healthcare Partners LLC | 134,842 | $2,056,341 | 0.55% |
| CANTOR FITZGERALD, L. P. | 301,690 | $4,601 | 0.10% |